Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease

A 62-year-old male with lung adenocarcinoma harboring an exon 19 deletion in the Epidermal growth factor receptor (EGFR) was treated with EGFR-tyrosine kinase inhibitors (TKIs) and several cytotoxic agents. After administering a fifth-line chemotherapy regimen, a liver biopsy revealed a diagnosis of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Kiriu, Tatsunori, Tamura, Daisuke, Tachihara, Motoko, Sekiya, Reina, Hazama, Daisuke, Katsurada, Masahiro, Nakata, Kyosuke, Nagano, Tatsuya, Yamamoto, Masatsugu, Kamiryo, Hiroshi, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5799064/
https://ncbi.nlm.nih.gov/pubmed/29033419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8947-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars